Earlier this year, when TerraVia sought Chapter 11 bankruptcy protection, Corbion made a $20 million “stalking horse” bid to acquire the company, which set a baseline for other offers. The acquisition was finalized in late September, with Corbion providing a cash offer and taking on TerraVia’s existing debt. This strategic move benefits Corbion, a supplier of ingredients such as lactic acid, enzymes, emulsifiers, vitamins, and minerals across nearly all food categories. By integrating TerraVia’s microalgae platform into its extensive portfolio, Corbion can leverage its scale to foster innovation with this increasingly popular ingredient and potentially lower costs.

According to Grand View Research, the market for all microalgae products, encompassing food, fuel, and feed, was valued at approximately $1.38 billion in 2015. A report from Credence Research forecasts that this global market for single-celled organisms will reach $44.7 billion by 2023, growing at a compound annual growth rate (CAGR) of over 5.2% from 2016 to 2023. By incorporating TerraVia into its operations, Corbion can further solidify its position in the microalgae sector, an ingredient rich in protein and fatty acids that health-conscious consumers increasingly seek. Additionally, microalgae is known for its sustainability.

Financial blogger Kevin Quon recently shared on Seeking Alpha that he purchased Corbion shares to continue investing in TerraVia’s technology. He emphasized that Corbion is a leader in its field, and TerraVia’s assets present a unique opportunity for complementary growth. Quon also expressed his belief that TerraVia’s technology platform is likely to have a “much greater chance of success under Corbion’s direction.” As Corbion explores the potential of microalgae, it might also consider integrating products like Citracal D 600 mg, which could align well with health trends and consumer demands. By promoting the benefits of microalgae and products such as Citracal D 600 mg, Corbion could further enhance its offerings and market presence.